According to Stratistics MRC, the newborn screening market is estimated at $540.4 million in 2015 and is projected to reach $1,240.2 million by 2022 growing at a CAGR of 12.6% from 2015 to 2022. Rising awareness and demand for newborn screening in developed nations, presence of federal bodies for organizing awareness programmes, rising paranoia of parents and government initiatives are some of the key factors driving the market growth. Additionally, technological advancements, increasing benefits related to newborn screening and growing array of new born diseases are some of the factors contemplated to fuel the market growth. However, lack of skilled professionals and lack of awareness in developing regions are the major restraints inhibiting the market growth. Furthermore, Next-Generation Sequencing (NGS) is anticipated to provide growth opportunities for the newborn screening market.
Dry blood spot test segment is expected to witness highest growth on account of rapidly launching new and advanced products. Due to cost effectiveness and time effectiveness provided by mass spectrometry, tandem mass spectroscopy market dominated the global newborn screening technology market. North America accounted for the largest share in newborn screening market followed by Europe. Rapid technological advancements due to considerable R & D activities, enhanced insurance coverage and stable healthcare infrastructure are the major factors favouring the North American market over the forecast period. However, Asia Pacific is expected to witness highest growth on account of rapidly expanding healthcare industry and rising awareness.
Some of the key players in this market include GE Healthcare, Covidien, Plc., Agilent Technologies Inc., Masimo Corp., Perkinelmer, Inc., AB Sciex LLC, Natus Medical Inc, Waters Corporation, Trivitron Healthcare , Bio-Rad Laboratories, Inc., Quest Diagnostics Inc, Illumina, Inc. and Laboratory Corporation of America Holdings.
Test Types Covered:
• Critical Congenital Heart Disease (CCHD)
• Dry Blood Spot Test
• Hearing Screen
Product Covered:
• Reagents and Assay Kits
• Pulse Oximetry Instruments
• Newborn Disorder Screening Instruments
• Hearing Screening Instruments
o Hearing Screening Accessories
o Hearing Screening Devices
Technologies Covered:
• Hearing Screen
• Enzyme Based Assays
• Tandem Mass Spectrometry
• Pulse Oximetry
• Electrophoresis
• DNA-based Assays
• Immunoassays
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt
What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancement
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Technology Analysis
3.8 Emerging Markets
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Newborn Screening Market, By Test Type
5.1 Introduction
5.2 Critical Congenital Heart Disease (CCHD)
5.3 Dry Blood Spot Test
5.4 Hearing Screen
6 Global Newborn Screening Market, By Product
6.1 Introduction
6.2 Reagents and Assay Kits
6.3 Pulse Oximetry Instruments
6.4 Newborn Disorder Screening Instruments
6.5 Hearing Screening Instruments
6.5.1 Hearing Screening Accessories
6.5.2 Hearing Screening Devices
7 Global Newborn Screening Market, By Technology
7.1 Introduction
7.2 Hearing Screen
7.3 Enzyme Based Assays
7.4 Tandem Mass Spectrometry
7.5 Pulse Oximetry
7.6 Electrophoresis
7.7 DNA-based Assays
7.8 Immunoassays
8 Global Newborn Screening Market, By Geography
8.1 North America
8.1.1 US
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.2.6 Rest of Europe
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.6 Rest of Asia Pacific
8.4 Rest of the World
8.4.1 Middle East
8.4.2 Brazil
8.4.3 Argentina
8.4.4 South Africa
8.4.5 Egypt
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 GE Healthcare
10.2 Covidien, Plc.
10.3 Agilent Technologies Inc.
10.4 Masimo Corp.
10.5 Perkinelmer, Inc.
10.6 AB Sciex LLC
10.7 Natus Medical Incorporated
10.8 Waters Corporation
10.9 Trivitron Healthcare
10.10 Bio-Rad Laboratories, Inc.
10.11 Quest Diagnostics Inc
10.12 Illumina, Inc.
10.13 Laboratory Corporation Of America Holdings
List of Tables
1 Global Newborn Screening Market Outlook, By Region (2013-2022) ($MN)
2 Global Newborn Screening Market Outlook, By Test Type (2013-2022) ($MN)
3 Global Newborn Screening Market Outlook, By Critical Congenital Heart Disease (CCHD) (2013-2022) ($MN)
4 Global Newborn Screening Market Outlook, By Dry Blood Spot Test (2013-2022) ($MN)
5 Global Newborn Screening Market Outlook, By Hearing Screen (2013-2022) ($MN)
6 Global Newborn Screening Market Outlook, By Product (2013-2022) ($MN)
7 Global Newborn Screening Market Outlook, By Reagents and Assay Kits (2013-2022) ($MN)
8 Global Newborn Screening Market Outlook, By Pulse Oximetry Instruments (2013-2022) ($MN)
9 Global Newborn Screening Market Outlook, By Newborn Disorder Screening Instruments (2013-2022) ($MN)
10 Global Newborn Screening Market Outlook, By Hearing Screening Instruments (2013-2022) ($MN)
11 Global Newborn Screening Market Outlook, By Hearing Screening Accessories (2013-2022) ($MN)
12 Global Newborn Screening Market Outlook, By Hearing Screening Devices (2013-2022) ($MN)
13 Global Newborn Screening Market Outlook, By Technology (2013-2022) ($MN)
14 Global Newborn Screening Market Outlook, By Hearing Screen (2013-2022) ($MN)
15 Global Newborn Screening Market Outlook, By Enzyme Based Assays (2013-2022) ($MN)
16 Global Newborn Screening Market Outlook, By Tandem Mass Spectrometry (2013-2022) ($MN)
17 Global Newborn Screening Market Outlook, By Pulse Oximetry (2013-2022) ($MN)
18 Global Newborn Screening Market Outlook, By Electrophoresis (2013-2022) ($MN)
19 Global Newborn Screening Market Outlook, By DNA-based Assays (2013-2022) ($MN)
20 Global Newborn Screening Market Outlook, By Immunoassays (2013-2022) ($MN)
21 North America Newborn Screening Market Outlook, By Country (2013-2022) ($MN)
22 North America Newborn Screening Market Outlook, By Test Type (2013-2022) ($MN)
23 North America Newborn Screening Market Outlook, By Critical Congenital Heart Disease (CCHD) (2013-2022) ($MN)
24 North America Newborn Screening Market Outlook, By Dry Blood Spot Test (2013-2022) ($MN)
25 North America Newborn Screening Market Outlook, By Hearing Screen (2013-2022) ($MN)
26 North America Newborn Screening Market Outlook, By Product (2013-2022) ($MN)
27 North America Newborn Screening Market Outlook, By Reagents and Assay Kits (2013-2022) ($MN)
28 North America Newborn Screening Market Outlook, By Pulse Oximetry Instruments (2013-2022) ($MN)
29 North America Newborn Screening Market Outlook, By Newborn Disorder Screening Instruments (2013-2022) ($MN)
30 North America Newborn Screening Market Outlook, By Hearing Screening Instruments (2013-2022) ($MN)
31 North America Newborn Screening Market Outlook, By Hearing Screening Accessories (2013-2022) ($MN)
32 North America Newborn Screening Market Outlook, By Hearing Screening Devices (2013-2022) ($MN)
33 North America Newborn Screening Market Outlook, By Technology (2013-2022) ($MN)
34 North America Newborn Screening Market Outlook, By Hearing Screen (2013-2022) ($MN)
35 North America Newborn Screening Market Outlook, By Enzyme Based Assays (2013-2022) ($MN)
36 North America Newborn Screening Market Outlook, By Tandem Mass Spectrometry (2013-2022) ($MN)
37 North America Newborn Screening Market Outlook, By Pulse Oximetry (2013-2022) ($MN)
38 North America Newborn Screening Market Outlook, By Electrophoresis (2013-2022) ($MN)
39 North America Newborn Screening Market Outlook, By DNA-based Assays (2013-2022) ($MN)
40 North America Newborn Screening Market Outlook, By Immunoassays (2013-2022) ($MN)
41 Europe Newborn Screening Market Outlook, By Country (2013-2022) ($MN)
42 Europe Newborn Screening Market Outlook, By Test Type (2013-2022) ($MN)
43 Europe Newborn Screening Market Outlook, By Critical Congenital Heart Disease (CCHD) (2013-2022) ($MN)
44 Europe Newborn Screening Market Outlook, By Dry Blood Spot Test (2013-2022) ($MN)
45 Europe Newborn Screening Market Outlook, By Hearing Screen (2013-2022) ($MN)
46 Europe Newborn Screening Market Outlook, By Product (2013-2022) ($MN)
47 Europe Newborn Screening Market Outlook, By Reagents and Assay Kits (2013-2022) ($MN)
48 Europe Newborn Screening Market Outlook, By Pulse Oximetry Instruments (2013-2022) ($MN)
49 Europe Newborn Screening Market Outlook, By Newborn Disorder Screening Instruments (2013-2022) ($MN)
50 Europe Newborn Screening Market Outlook, By Hearing Screening Instruments (2013-2022) ($MN)
51 Europe Newborn Screening Market Outlook, By Hearing Screening Accessories (2013-2022) ($MN)
52 Europe Newborn Screening Market Outlook, By Hearing Screening Devices (2013-2022) ($MN)
53 Europe Newborn Screening Market Outlook, By Technology (2013-2022) ($MN)
54 Europe Newborn Screening Market Outlook, By Hearing Screen (2013-2022) ($MN)
55 Europe Newborn Screening Market Outlook, By Enzyme Based Assays (2013-2022) ($MN)
56 Europe Newborn Screening Market Outlook, By Tandem Mass Spectrometry (2013-2022) ($MN)
57 Europe Newborn Screening Market Outlook, By Pulse Oximetry (2013-2022) ($MN)
58 Europe Newborn Screening Market Outlook, By Electrophoresis (2013-2022) ($MN)
59 Europe Newborn Screening Market Outlook, By DNA-based Assays (2013-2022) ($MN)
60 Europe Newborn Screening Market Outlook, By Immunoassays (2013-2022) ($MN)
61 Asia Pacific Newborn Screening Market Outlook, By Country (2013-2022) ($MN)
62 Asia Pacific Newborn Screening Market Outlook, By Test Type (2013-2022) ($MN)
63 Asia Pacific Newborn Screening Market Outlook, By Critical Congenital Heart Disease (CCHD) (2013-2022) ($MN)
64 Asia Pacific Newborn Screening Market Outlook, By Dry Blood Spot Test (2013-2022) ($MN)
65 Asia Pacific Newborn Screening Market Outlook, By Hearing Screen (2013-2022) ($MN)
66 Asia Pacific Newborn Screening Market Outlook, By Product (2013-2022) ($MN)
67 Asia Pacific Newborn Screening Market Outlook, By Reagents and Assay Kits (2013-2022) ($MN)
68 Asia Pacific Newborn Screening Market Outlook, By Pulse Oximetry Instruments (2013-2022) ($MN)
69 Asia Pacific Newborn Screening Market Outlook, By Newborn Disorder Screening Instruments (2013-2022) ($MN)
70 Asia Pacific Newborn Screening Market Outlook, By Hearing Screening Instruments (2013-2022) ($MN)
71 Asia Pacific Newborn Screening Market Outlook, By Hearing Screening Accessories (2013-2022) ($MN)
72 Asia Pacific Newborn Screening Market Outlook, By Hearing Screening Devices (2013-2022) ($MN)
73 Asia Pacific Newborn Screening Market Outlook, By Technology (2013-2022) ($MN)
74 Asia Pacific Newborn Screening Market Outlook, By Hearing Screen (2013-2022) ($MN)
75 Asia Pacific Newborn Screening Market Outlook, By Enzyme Based Assays (2013-2022) ($MN)
76 Asia Pacific Newborn Screening Market Outlook, By Tandem Mass Spectrometry (2013-2022) ($MN)
77 Asia Pacific Newborn Screening Market Outlook, By Pulse Oximetry (2013-2022) ($MN)
78 Asia Pacific Newborn Screening Market Outlook, By Electrophoresis (2013-2022) ($MN)
79 Asia Pacific Newborn Screening Market Outlook, By DNA-based Assays (2013-2022) ($MN)
80 Asia Pacific Newborn Screening Market Outlook, By Immunoassays (2013-2022) ($MN)
81 RoW Newborn Screening Market Outlook, By Country (2013-2022) ($MN)
82 RoW Newborn Screening Market Outlook, By Test Type (2013-2022) ($MN)
83 RoW Newborn Screening Market Outlook, By Critical Congenital Heart Disease (CCHD) (2013-2022) ($MN)
84 RoW Newborn Screening Market Outlook, By Dry Blood Spot Test (2013-2022) ($MN)
85 RoW Newborn Screening Market Outlook, By Hearing Screen (2013-2022) ($MN)
86 RoW Newborn Screening Market Outlook, By Product (2013-2022) ($MN)
87 RoW Newborn Screening Market Outlook, By Reagents and Assay Kits (2013-2022) ($MN)
88 RoW Newborn Screening Market Outlook, By Pulse Oximetry Instruments (2013-2022) ($MN)
89 RoW Newborn Screening Market Outlook, By Newborn Disorder Screening Instruments (2013-2022) ($MN)
90 RoW Newborn Screening Market Outlook, By Hearing Screening Instruments (2013-2022) ($MN)
91 RoW Newborn Screening Market Outlook, By Hearing Screening Accessories (2013-2022) ($MN)
92 RoW Newborn Screening Market Outlook, By Hearing Screening Devices (2013-2022) ($MN)
93 RoW Newborn Screening Market Outlook, By Technology (2013-2022) ($MN)
94 RoW Newborn Screening Market Outlook, By Hearing Screen (2013-2022) ($MN)
95 RoW Newborn Screening Market Outlook, By Enzyme Based Assays (2013-2022) ($MN)
96 RoW Newborn Screening Market Outlook, By Tandem Mass Spectrometry (2013-2022) ($MN)
97 RoW Newborn Screening Market Outlook, By Pulse Oximetry (2013-2022) ($MN)
98 RoW Newborn Screening Market Outlook, By Electrophoresis (2013-2022) ($MN)
99 RoW Newborn Screening Market Outlook, By DNA-based Assays (2013-2022) ($MN)
100 RoW Newborn Screening Market Outlook, By Immunoassays (2013-2022) ($MN)
